SEA Vision is a leading supplier of industrial vision inspection systems for the pharmaceutical industry since 1995 and builds its success on the excellence of its technological solutions. They develop software for products quality control, track & trace, digitalization and process automation solutions. To date, the company has installed over 2500 complete serialization lines and over 10.500 vision systems worldwide. Their long-standing expertise in innovative projects and constant commitment to research and development ensure the company offers its customers the best technology solutions possible for highly complex innovative projects. In 2019 the company acquired 100% of the competing company Lixis, becoming an international group with a workforce of over 420 employees worldwide. In 2020 the Group announces the 100% acquisition of ARGO Vision, an Italian startup specialized in the development of Artificial Intelligence solutions with a focus on Computer Vision, thus marking a new important step for the enhancement of yudoo Suite, the central fulcrum of SEA Vision current strategy. Thanks to its network of technical and commercial offices, SEA Vision provides worldwide customer care services such as customer-tailored trainings and on-site technical assistance. For further information please visit: www.seavision-group.com

" SMA company was founded in 1995,and was restructured to Shandong SMA Pharmatech Co., LTD in 2014.Main products includingCapsule filling machine,Tablet press machine,Roller compactor,High Shear Mixer,FBD,Coater,Blister&Cartoner;provide Oncology Production Solution(OEB4-5),Continuous manufacturing solution,Solid dosage overall sulution."

Shanghai Pharmaceutical Machinery Co., Ltd (SPM) specialized in designing and manufacturing pharmaceutical machinery. We have strong technical power and absorbed the technical essence from abroad constantly. With the cooperation of the research institute and design institute, SPM offers newly generated machinery products, which fully comply with GMP requirements. We continue to promote quality systems for global customers and strengthen our core competitiveness to move forward in serving the pharmaceutical industry.